SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001600132-19-000020
Filing Date
2019-01-07
Accepted
2019-01-07 08:37:37
Documents
3
Period of Report
2019-01-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjanuary2019ildupdate.htm 8-K 28471
2 EXHIBIT 99.1 a8-kjan2019ildupdateex991.htm EX-99.1 15627
3 blphlogoa44.jpg GRAPHIC 32979
  Complete submission text file 0001600132-19-000020.txt   90835
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36845 | Film No.: 19512301
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1